Assertio Holdings (ASRT) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Geopolitik keskinliklar nevrologik dori vositalari eksportini va xorijiy moddalardan foydalanish imkoniyatlarini cheklamoqda. Uzoq muddatli qarzlarning kapitalga nisbati xavfni baholash imkonini beradi, bunda 0.52 baza parametr qiymati vazifasini o'taydi. Analgetiklarga bo'lgan talab barqarorligicha qolmoqda, bu esa biznesning iqtisodiy sikllarga chidamliligini ta'minlaydi. Shu bilan birga, Assertio Holdings, Inc. (ASRT) logistika markazlari va qadoqlash quvvatlari uzilishlarsiz ishlamoqda.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_ASRT_-_Assertio-Holdings-Inc._-_Long-Term-Debt-to-Equity-Ratio "ASRT - Assertio Therapeutics Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 27.06.2026 oraligʻida | 👁️GURU.Markets👁️")
Assertio Holdings (ASRT) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Assertio Holdings, Inc.|ASRT - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Assertio Therapeutics|ASRT - Kompaniya qarzlari|Sof aktivlarga qarzlar Assertio Holdings, Inc.|ASRT - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Assertio|Shoshilinch likvidlik assertiotx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:Assertio Holdings, Inc.
Assertio Holdings, Inc. (ASRT) kompaniyasida nevrologiya patentlari bilan bog'liq xatarlardan kelib chiqqan foyda tebranishlari majburiyatlar tuzilmasini qat'iy nazorat qilishni taqozo etadi. Ushbu koeffitsient bir yildan ortiq muddatli majburiyatlarni kapital bilan bog'laydi. Bu beqaror pul oqimlari sharoitida biznesning tashqi qarzga bog'liqligini baholash imkonini beradi. Kredit yukini kamaytirish talabning pasayishi davrlarida kompaniyaning omon qolishini ta'minlaydi. Qarzga tegishli uzoq muddatli moliyaviy barqarorlik ko'rsatkichining tendentsiyasi emitentning xavfsizlik zaxirasini belgilaydi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Uzoq muddatli qarzdorlikning kapitalga nisbati Amylyx Pharmaceuticals Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Uzoq muddatli qarzdorlikning kapitalga nisbati Praxis Corp (PRAX)|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ceribell.com|Prothena Corp (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alector - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|OMER (Omeros Corp.) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzdorlikning kapitalga nisbati acimmune.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Voyager Therapeutics, Inc. VYGR|Neumora (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SCLX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG: Uzoq muddatli qarzning kapitalga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|Uzoq muddatli majburiyatlarning kapitalga nisbati Cassava Sciences Inc SAVA|Uzoq muddatli qarzning o'z kapitaliga nisbati Coya Therapeutics, Inc. (COYA)|Uzoq muddatli qarzning o'z kapitaliga nisbati VTGN (vistagen.com)|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|ABOS: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|CervoMed - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Alterity Therapeutics ATHE|clene.com (CLNN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi PEPG|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning kapitalga nisbati|RLMD - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio (ANVS)|Uzoq muddatli qarzdorlikning kapitalga nisbati gracetx.com|Firefly Neuroscience Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KLTO|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati revivapharma.com RVPH|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NRXS|HSDT (Helius Medical Technologies, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio Corp (PASG)|Uzoq muddatli qarzning o'z kapitaliga nisbati NEUP (Neuphoria Therapeutics Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|Uzoq muddatli qarzning kapitalga nisbati Addex Therapeutics Ltd. ADXN|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Cyclerion Therapeutics CYCN|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pasithea Therapeutics Corp. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|ATXI (Avenue Therapeutics Inc.) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning kapitalga nisbati Trevena Inc. (TRVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Uzoq muddatli qarzdorlikning kapitalga nisbati Anew Medical Inc. (WENA)|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati